Literature DB >> 34134863

Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.

Tyler S Bartholomew1, Daniel J Feaster2, Hardik Patel2, David W Forrest3, Hansel E Tookes4.   

Abstract

INTRODUCTION: Syringe services programs (SSPs) are evidence-based HIV prevention programs for people who inject drugs. However, not all SSPs operate evidence-based syringe distribution models, such as needs-based distribution. This study aims to provide preliminary evidence from the IDEA SSP on changes in injection risk behaviors over time, and to examine factors, including syringe coverage, associated with injection risk behavior trajectories over time under a one-for-one syringe distribution model.
METHODS: We used a prospective observational study design to generate a cohort of SSP clients who completed three behavioral assessments at SSP service visits between December 2016 and January 2020 (N = 115). The study used generalized estimating equations (GEE) to examine the relationship between covariate measures and the primary outcomes. The primary outcomes were 1) sharing of any injection equipment (e.g. syringes, needles, cookers, cottons) in the previous 30 days (yes/no) and 2) reusing of needles/syringes in the previous 30 days (yes/no).
RESULTS: Men were more likely to report reusing syringes (aRR = 1.15, 95% CI: 1.01-1.37) and those who reported injecting in public were less likely to report reusing syringes (aRR = 0.90, 95% CI: 0.82-0.99). HCV-positive clients had a 62% reduction in sharing injection equipment and those who reported public injection had a 62% increase in sharing injection equipment over time. Most importantly, increasing syringe coverage was associated with a decrease in both sharing injection equipment (aRR = 0.42, 95% CI: 0.25-0.72) and reusing syringes (aRR = 0.79, 95% CI: 0.66-0.95).
CONCLUSION: This study provides preliminary evidence of reductions in injection-related risk behaviors from the IDEA SSP and highlights potential high priority groups, such as people experiencing homelessness, that may need additional intervention. In addition, improving syringe coverage among SSP clients may be an important factor in reducing behaviors that place individuals at risk for contracting HIV and HCV.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV/HCV prevention; People who inject drugs; Syringe services program

Mesh:

Year:  2021        PMID: 34134863      PMCID: PMC8221088          DOI: 10.1016/j.jsat.2021.108344

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  52 in total

1.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

Authors:  Ricky N Bluthenthal; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

2.  Public injection settings in Vancouver: physical environment, social context and risk.

Authors:  Will Small; Tim Rhodes; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2007-02-07

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Significant decrease in injection risk behaviours among participants in a needle exchange programme.

Authors:  Martin Kåberg; Niklas Karlsson; Andrea Discacciati; Katarina Widgren; Ola Weiland; Anna Mia Ekström; Anders Hammarberg
Journal:  Infect Dis (Lond)       Date:  2020-02-19

5.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.

Authors:  Frederick L Altice; Sandra Springer; Marta Buitrago; David P Hunt; Gerald H Friedland
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

7.  Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.

Authors:  Julie Bruneau; Geng Zang; Michal Abrahamowicz; Didier Jutras-Aswad; Mark Daniel; Elise Roy
Journal:  Clin Infect Dis       Date:  2013-12-20       Impact factor: 9.079

8.  Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois.

Authors:  Dezheng Huo; Lawrence J Ouellet
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

9.  Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions.

Authors:  Norah E Palmateer; Avril Taylor; David J Goldberg; Alison Munro; Celia Aitken; Samantha J Shepherd; Georgina McAllister; Rory Gunson; Sharon J Hutchinson
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

10.  Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program.

Authors:  Marcus A Bachhuber; Cole Thompson; Ann Prybylowski; José Benitez; Silvana Mazzella; David Barclay
Journal:  Subst Abus       Date:  2018-05-04       Impact factor: 3.984

View more
  1 in total

1.  The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.

Authors:  Kinna Thakarar; Michael Kohut; Rebecca Hutchinson; Rebecca Bell; Hannah E Loeb; Debra Burris; Kathleen M Fairfield
Journal:  Harm Reduct J       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.